p-value Group has been acquired by Publicis Groupe
September 2025 — p-value Group, one of the largest independent medical communications agencies in North America, has been acquired by Publicis Groupe (ENXTPA:PUB) for its strong strategic fit, global scale and cultural alignment. The acquisition enhances Publicis Groupe’s medical communications capabilities in the USA and supports its broader strategy of integrating science-first solutions across its global network.
Founded in 2004 by Linda Corvari, p-value is a leading full-service provider of medical and scientific communications, serving marquee clients across the life sciences sector. The company specializes in medical strategy, scientific communications, content development and speaker bureau management, earning a strong reputation for scientific rigor, exceptional client service and a culture of excellence. p-value maintains diverse and expanding expertise across therapeutic areas, with particularly strong experience in dermatology.
Publicis Groupe, founded in 1926 and headquartered in Paris, France, is the world's second-largest advertising holding company by revenue. The group offers a broad range of services, including traditional and digital advertising, public relations and consulting. It employs approximately 108,000 people worldwide, with over 80% of its revenue generated from developed markets, particularly North America and Europe.
Our role in the transaction
Oaklins Intrepid in Los Angeles acted as the exclusive sell-side advisor in this transaction, highlighting the team’s deep domain expertise in the pharmaceutical services sector and broader marketing agency landscape.
Talk to the deal team
Adam Abramowitz
Oaklins Intrepid
Greg Passani
Oaklins Intrepid
Related deals
IXICO has completed a fundraising
IXICO plc, a specialist in AI-driven neuroimaging analytics, has completed a gross capital raise of US$13.5 million. The funds will be used to support the company’s tech bio strategy, enabling IXICO to partner its platform more broadly and maximize its potential.
Learn moreRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn moreYooli has sold a minority stake to La Poste Santé & Autonomie and La Poste Ventures
Yooli has sold a minority stake to La Poste Ventures, the investment fund of La Poste Santé & Autonomie, following a process conducted in France and internationally. The entry of La Poste Ventures, a recognized player in the healthcare sector, reflects a shared vision to support the digital transformation of healthcare institutions through pragmatic, secure and user-centric solutions focused on the needs of healthcare professionals and patients.
Learn more